Acromegaly accompanied by Turner syndrome with 47,XXX/45,X/46,XX mosaicism

Internal Medicine

Volumn 48, Issue 6, 2009, Pages 447-453

  Yamazaki, Masanori ^a   Sato, Ai ^a   Nishio, Shin Ichi ^a   Takeda, Teiji ^a   Miyamoto, Takahide ^a   Katai, Miyuki ^b   Hashizume, Kiyoshi ^a  

^a SHINSHU UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

47; Acromegaly; Mosaicism; Turner syndrome; XXX

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; ARTICLE; CASE REPORT; CHROMOSOME ANALYSIS; CHROMOSOME MOSAICISM; DISEASE ASSOCIATION; FEMALE; GROWTH HORMONE BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOPHARYNX; HYPOPHYSIS ADENOMA; KARYOTYPE 45,X; KARYOTYPE 46,XX; KARYOTYPE 47,XXX; PHARYNX DISEASE; PIGMENTED NEVUS; PREMATURE OVARIAN FAILURE; SHORT STATURE; TRANSSPHENOIDAL HYPOPHYSECTOMY; TURNER SYNDROME; VALGUS DEFORMITY;

ACROMEGALY; ADENOMA; ADULT; CHROMOSOMES, HUMAN, X; DIAGNOSIS, DIFFERENTIAL; FEMALE; GROWTH HORMONE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MAGNETIC RESONANCE IMAGING; MOSAICISM; PITUITARY NEOPLASMS; TURNER SYNDROME;

EID: 67650070304     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.1157     Document Type: Article

References (29)

1. Elsheikh M, Dunger DB, Conway GS, Wass JA. Turner's syndrome in adulthood. Endocr Rev 23: 120-140, 2002.
2. Sybert VP, McCauley E. Turner's syndrome. N Engl J Med 351: 1227-1238, 2004.
3. Gravholt CH. Epidemiological, endocrine and metabolic features in Turner syndrome. Eur J Endocrinol 151: 657-687, 2004.
4. Bondy CA. New issues in the diagnosis and management of Turner syndrome. Rev Endocr Metab Disord 6: 269-280, 2005.
5. Gravholt CH. Clinical practice in Turner syndrome. Nat Clin Pratt Endocrinol Metab 1: 41-52, 2005.
6. Melmed S. Disorders of the anterior pituitary and hypothalamus. In: Harrison's Principle of Internal Medicine. 15th ed. Braunwald E FA KD, Hauser SL, et al., McGraw-Hill, New York, 2001: 2029-2052.
7. Wallerstein R, Musen E, McCarrier J, et al. Turner syndrome phenotype with 47,XXX karyotype: further investigation warranted? Am J Med Genet A 125A: 106-107, 2004.
8. Sybert VP. Phenotypic effects of mosaicism for a 47,XXX cell line in Turner syndrome. J Med Genet 39: 217-220, 2002.
9. Alvarez-Vázquez P, Rivera A, Figueroa I, Páramo C, García-Mayor RV. Acromegaloidism with normal growth hormone secretion associated with X-tetrasomy. Pituitary 9: 145-149, 2006.
10. Partsch CJ, Pankau R, Sippell WG, Tolksdorf M. Normal growth and normalization of hypergonadotropic hypogonadism in atypical Turner syndrome (45,X/46,XX/47,XXX). Correlation of body height with distribution of cell lines. Eur J Pediatr 153: 451-455, 1994.
11. Ogata T, Muroya K, Matsuo N, et al. Turner syndrome and Xp deletions: clinical and molecular studies in 47 patients. J Clin Endocrinol Metab 86: 5498-5508, 2001.
12. Sybert VP. Turner syndrome. In: Management of genetic syndrome. Cassidy SB, Allanson JE, Eds. Wiley-Liss, Inc, New York, 2001: 459-484.
13. Fatti LM, Scacchi M, Pincelli AI, Lavezzi E, Cavagnini F. Prevalence and pathogenesis of sleep apnea and lung disease in acromegaly. Pituitary 4: 259-262, 2001.
14. Miale T, Stenke L, Lindsten J, Reizenstein P. Iron malabsorption and hypochromic anemia in a case of Turner's syndrome. Experientia 34: 1220, 1978.
15. Bonamico M, Pasquino AM, Mariani P, et al. Prevalence and clinical picture of celiac disease in Turner syndrome. J Clin Endocrinol Metab 87: 5495-5498, 2002.
16. Gáspár L, Julesz J, Kocsis J, Pásztor E, László F. Mosaic Turner's syndrome and pituitary microadenoma. Exp Clin Endocrinol 86: 87-92, 1985.
17. Lapidot M, Vilner Y, Pinkhas J, Shindel B, Weinstein R, Sidi Y. Coexistence of low secretion of gonadotropins and ACTH in a patient with gonadal dysgenesis and pituitary tumor. Isr J Med Sci 26: 398-401, 1990.
18. Pejaver RK, Watson AH. Pituitary microadenoma in Turner's syndrome. Br J Clin Pratt 49: 223-224, 1995.
19. Mermilliod JA, Gatchair-Rose A, Svec F. Pituitary tumor and low gonadotropins in a patient with Turner's syndrome. J La State Med Soc 147: 540-543, 1995.
20. Dötsch J, Schoof E, Hensen J, Dörr HG. Prolactinoma causing secondary amenorrhea in a woman with Ullrich-Turner syndrome. Horm Res 51: 256-257, 1999.
21. Scheithauer BW, Kovacs K, Horvath E, Young WF Jr., Lloyd RV. The pituitary in Turner syndrome. Endocr Pathol 16: 195-200, 2005.
22. Bolanowski M, Łomna-Bogdanov E, Kosmala W, et al. Turner's syndrome followed by acromegaly in the third decade of life: an unusual coincidence of two rare conditions. Gynecol Endocrinol 16: 331-334, 2002.
23. Lebl J, Proůhová S, Zapletalová J, Pechová M. IGF-I resistance and Turner's syndrome. J Pediatr Endocrinol Metab 14: 37-41, 2001.
24. Rosenfeld RG, Hwa V. New molecular mechanisms of GH resistance. Eur J Endocrinol 151 Suppl 1: S11-S15, 2004.
25. Meinhardt UJ, Ho KK. Modulation of growth hormone action by sex steroids. Clin Endoerinol (Oxf) 65: 413-422, 2006.
26. Savage MO, Attie KM, David A, Metherell LA, Clark AJ, Camacho-Hübner C. Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders. Nat Clin Pract Endocrinol Metab 2: 395-407, 2006.
27. Walenkamp MJ, Wit JM. Genetic disorders in the GH-IGF-I axis in mouse and man. Eur J Endocrinol 157 Suppl 1: S15-S26, 2007.
28. Frohman LA, Kineman RD. Growth hormone-releasing hormone and pituitary development, hyperplasia and tumorigenesis. Trends Endocrinol Metab 13: 299-303, 2002.
29. de Menis E, Gola M, Giustina A. Development of acromegaly in a patient with anorexia nervosa: pathogenetic and diagnostic implications. J Endocrinol Invest 29: 821-825, 2006.